AR022470A1 - Uso de pirazol-carboxamidas - Google Patents

Uso de pirazol-carboxamidas

Info

Publication number
AR022470A1
AR022470A1 ARP000100428A ARP000100428A AR022470A1 AR 022470 A1 AR022470 A1 AR 022470A1 AR P000100428 A ARP000100428 A AR P000100428A AR P000100428 A ARP000100428 A AR P000100428A AR 022470 A1 AR022470 A1 AR 022470A1
Authority
AR
Argentina
Prior art keywords
carboxamids
pirazol
pyrazolcarboxamides
novel
pyrazolecarboxamides
Prior art date
Application number
ARP000100428A
Other languages
English (en)
Spanish (es)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR022470A1 publication Critical patent/AR022470A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP000100428A 1999-02-04 2000-02-01 Uso de pirazol-carboxamidas AR022470A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19904397A DE19904397A1 (de) 1999-02-04 1999-02-04 Verwendung von Pyrazol-Carbonsäureamiden

Publications (1)

Publication Number Publication Date
AR022470A1 true AR022470A1 (es) 2002-09-04

Family

ID=7896339

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100428A AR022470A1 (es) 1999-02-04 2000-02-01 Uso de pirazol-carboxamidas

Country Status (8)

Country Link
EP (1) EP1148879A2 (fr)
JP (1) JP2002536348A (fr)
AR (1) AR022470A1 (fr)
AU (1) AU3150300A (fr)
CA (1) CA2361636A1 (fr)
DE (1) DE19904397A1 (fr)
GT (1) GT200000009A (fr)
WO (1) WO2000045894A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878729B2 (en) * 2001-05-04 2005-04-12 The Procter & Gamble Company Medicinal uses of dihydropyrazoles
US8710038B2 (en) 2004-09-17 2014-04-29 Exelixis, Inc. Pyrazole kinase modulators and methods of use
UY30892A1 (es) 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
CA2750565C (fr) 2009-01-30 2015-10-20 Glaxosmithkline Llc Chlorhydrate de n-{(1-s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide cristallin
EP4173485A1 (fr) * 2021-10-27 2023-05-03 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Composés inhibant l'agrégation de protéine pour la lutte contre les maladies des plantes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
US5434178A (en) * 1993-11-30 1995-07-18 G.D. Searle & Co. 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
AU7564296A (en) * 1995-11-17 1997-06-11 Ciba-Geigy Ag Solid phase synthesis of heterocyclic compounds and combinatorial compound library
DE19904396A1 (de) * 1999-02-04 2000-08-10 Bayer Ag Substituierte Pyrazolbenzylamin-Derivate
DE19904406A1 (de) * 1999-02-04 2000-08-10 Bayer Ag Substituierte Pyrazolcarbonsäuren

Also Published As

Publication number Publication date
AU3150300A (en) 2000-08-25
EP1148879A2 (fr) 2001-10-31
GT200000009A (es) 2001-07-27
CA2361636A1 (fr) 2000-08-10
JP2002536348A (ja) 2002-10-29
WO2000045894A2 (fr) 2000-08-10
WO2000045894A3 (fr) 2001-04-19
DE19904397A1 (de) 2000-08-10

Similar Documents

Publication Publication Date Title
SE0001899D0 (sv) New compounds
BR0113234A (pt) Polimorfos de um análogo de epotilona
BR0017026A (pt) Lipeptìdeos como agentes antibacterianos
BR0108677A (pt) Novos compostos
BR0208338A (pt) Derivados de piridina
BR0112589A (pt) Derivados de heteroarila e sua aplicação como medicamento
BR0211801A (pt) Derivados de 7h-pirrolo[2,3-d]pirimidina
BR0214469A (pt) 17alfa-alquil-17beta-óxi-estratrienos e produtos intermediários para sua preparação, aplicação dos 17alfa-alquil-17beta-óxi-estratrienos para a preparação de medicamentos bem como preparações farmacêuticas
MEP39108A (en) Pharmaceutical composition
BRPI0409136A (pt) composto heteroaromático pentacìclico e uso medicinal do mesmo
UY27368A1 (es) Nuevos compuestos
BRPI0414948A (pt) derivados de pirazolo-e-imidazo pirimidina
BR0017028A (pt) Lipopepìdeos como agentes antibacterianos
BR0016467A (pt) Lipopeptìdeos como agentes antibacterianos
BR0111358A (pt) Compostos de tioacetamida e seu uso
AR022469A1 (es) Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias
BR0209129A (pt) Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos
BR0208887A (pt) Derivados de dihidro-benzo[b][1,4]diazepin-2-ona como antagonistas i de mglur2
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR0015147A (pt) Ciclopropanos como cgrp-antagonistas, medicamentos contendo os ditos compostos e processo para a produção dos mesmos
BR9916680A (pt) Derivados da 3,3-biarilpiperidina e2,2-biarilmorfolina
BRPI0513287A (pt) derivados de pirido-pirimidina, sua preparação, sua aplicação em terapêutica
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
BR0014233A (pt) Conjugados de 4-benzilaminoquinolina com ácido galênico e seus heteroanálogos, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação
BRPI0412928A (pt) dibenzo[b,f]oxepina-10-carboxamidas e usos farmacêuticos das mesmas